Compass Therapeutics, Inc. (CMPX) Q1 2025 Earnings
CMPX·Reported May 8, 2025·Before market open
Diluted EPS came in at $-0.12 (-50.0% YoY).
Diluted EPS
$-0.12met estimate
Consensus: $-0.12
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Compass Therapeutics, Inc.'s Q1 2025 earnings report.
Compass Therapeutics, Inc. (CMPX) reported Q1 2025 earnings on May 8, 2025 before market open.
Compass Therapeutics, Inc. reported diluted EPS of $-0.12 for Q1 2025.
EPS beat the consensus estimate of $-0.12 by $0.00.
Compared to the same quarter a year prior, diluted EPS declined 50.0% from $-0.08.
You can read the 10-Q periodic report (0001171843-25-002953) directly on SEC EDGAR. The filing index links above go to sec.gov.